genedrive plc (GDR) - Total Assets
Based on the latest financial reports, genedrive plc (GDR) holds total assets worth GBX2.81 Million GBX (≈ $342.50 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See GDR net asset value for net asset value and shareholders' equity analysis.
genedrive plc - Total Assets Trend (2006–2025)
This chart illustrates how genedrive plc's total assets have evolved over time, based on quarterly financial data.
genedrive plc - Asset Composition Analysis
Current Asset Composition (June 2025)
genedrive plc's total assets of GBX2.81 Million consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 42.0% |
| Accounts Receivable | GBX1.07 Million | 38.2% |
| Inventory | GBX428.00K | 15.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how genedrive plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see genedrive plc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: genedrive plc's current assets represent 95.4% of total assets in 2025, an increase from 76.2% in 2006.
- Cash Position: Cash and equivalents constituted 42.0% of total assets in 2025, down from 45.7% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 38.2% of total assets.
genedrive plc Competitors by Total Assets
Key competitors of genedrive plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
genedrive plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 4.60 | 4.67 |
| Quick Ratio | 1.64 | 4.33 | 4.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.31 Million | GBX5.18 Million | GBX8.06 Million |
genedrive plc - Advanced Valuation Insights
This section examines the relationship between genedrive plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.80 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -58.6% |
| Total Assets | GBX2.81 Million |
| Market Capitalization | $119.01K USD |
Valuation Analysis
Below Book Valuation: The market values genedrive plc's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: genedrive plc's assets decreased by 58.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for genedrive plc (2006–2025)
The table below shows the annual total assets of genedrive plc from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX2.81 Million ≈ $342.50 |
-58.60% |
| 2024-06-30 | GBX6.80 Million ≈ $827.36 |
+50.88% |
| 2023-06-30 | GBX4.51 Million ≈ $548.37 |
-31.93% |
| 2022-06-30 | GBX6.62 Million ≈ $805.58 |
+35.76% |
| 2021-06-30 | GBX4.88 Million ≈ $593.39 |
-53.34% |
| 2020-06-30 | GBX10.45 Million ≈ $1.27K |
+44.04% |
| 2019-06-30 | GBX7.26 Million ≈ $882.97 |
+22.83% |
| 2018-06-30 | GBX5.91 Million ≈ $718.83 |
-50.95% |
| 2017-06-30 | GBX12.05 Million ≈ $1.47K |
+1.60% |
| 2016-06-30 | GBX11.86 Million ≈ $1.44K |
-25.87% |
| 2015-06-30 | GBX15.99 Million ≈ $1.95K |
+9.42% |
| 2014-06-30 | GBX14.62 Million ≈ $1.78K |
+3.87% |
| 2013-06-30 | GBX14.07 Million ≈ $1.71K |
+34.44% |
| 2012-06-30 | GBX10.47 Million ≈ $1.27K |
+34.04% |
| 2011-06-30 | GBX7.81 Million ≈ $950.13 |
-0.03% |
| 2010-06-30 | GBX7.81 Million ≈ $950.37 |
+32.03% |
| 2009-06-30 | GBX5.92 Million ≈ $719.81 |
+87.10% |
| 2008-06-30 | GBX3.16 Million ≈ $384.72 |
-5.30% |
| 2007-06-30 | GBX3.34 Million ≈ $406.26 |
+124.24% |
| 2006-06-30 | GBX1.49 Million ≈ $181.17 |
-- |
About genedrive plc
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnos… Read more